Author

Xiaojia Huang

Observed names: Huang, Xiaojia, X. Huang, X.-J. Huang, Xiao-Jia Huang, Xiao-jia Huang

Institutions: Northwestern University, Lurie Children's Hospital, Fujian Medical University, Sun Yat-sen University, Sixth Affiliated Hospital of Sun Yat-sen University, First Affiliated Hospital of Fujian Medical University, Guangdong Academy of Medical Sciences, Guangzhou Medical University Cancer Hospital, Guangdong Provincial People's Hospital, Southern Medical University, Guangzhou Medical University

Observed institutions: National Natural Science Foundation of China, Northwestern University, Jiangsu University, Lurie Children's Hospital, Fujian Medical University, Sun Yat-sen University, University of Illinois Chicago, Sixth Affiliated Hospital of Sun Yat-sen University, Sun Yat-sen Memorial Hospital, First Affiliated Hospital of Fujian Medical University, Guangdong Academy of Medical Sciences, Sun Yat-sen University Cancer Center, Guangzhou Medical University Cancer Hospital, Guangdong Provincial People's Hospital, State Key Laboratory of Oncology in South China, Chengdu University of Traditional Chinese Medicine, Southern Medical University, Guangzhou Medical University

ORCID: 0000-0002-4536-3847

Observed ORCID: 0000-0002-4536-3847

OpenAlex ID: A5100768340

circEPSTI1 as a Prognostic Marker and Mediator of Triple-Negative Breast Cancer Progression

2018 · Bo Chen, Weidong Wei, et al. · Theranostics · 281

PDF

circKIF4A acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer

2019 · Hailin Tang, Xiaojia Huang, et al. · Molecular Cancer · 208

The miR-34a-LDHA axis regulates glucose metabolism and tumor growth in breast cancer

2016 · Xiangsheng Xiao, Xiaojia Huang, et al. · Scientific Reports · 132

PDF

Glioblastoma Stem-Like Cells: Characteristics, Microenvironment, and Therapy

2016 · Yang Yi, I-Yun Hsieh, et al. · Frontiers in Pharmacology · 116

PDF

Drug Delivery Using Nanoparticles for Cancer Stem-Like Cell Targeting

2016 · Bing Lu, Xiaojia Huang, et al. · Frontiers in Pharmacology · 76

PDF

SOX2 Promotes Cell Proliferation and Metastasis in Triple Negative Breast Cancer

2018 · Peng Liu, Hailin Tang, et al. · Frontiers in Pharmacology · 72

PDF

PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a

2017 · Xiaojia Huang, Xinhua Xie, et al. · Journal of Experimental & Clinical Cancer Research · 72

PDF

AHNAK suppresses tumour proliferation and invasion by targeting multiple pathways in triple-negative breast cancer

2017 · Bo Chen, Jin Wang, et al. · Journal of Experimental & Clinical Cancer Research · 71

PDF

Nanoparticle enhanced combination therapy for stem-like progenitors defined by single-cell transcriptomics in chemotherapy-resistant osteosarcoma

2020 · Li Wang, Xiaojia Huang, et al. · Signal Transduction and Targeted Therapy · 70

PDF

Adam12 and lnc015192 act as ceRNAs in breast cancer by regulating miR-34a

2018 · Xiaojia Huang, Xinhua Xie, et al. · Oncogene · 70

mir-101-3p is a key regulator of tumor metabolism in triple negative breast cancer targeting AMPK

2016 · Peng Liu, Feng Ye, et al. · Oncotarget · 68

Endothelial FoxM1 reactivates aging-impaired endothelial regeneration for vascular repair and resolution of inflammatory lung injury

2023 · Xiaojia Huang, Xianming Zhang, et al. · Science Translational Medicine · 65

PDF

Metformin mediates induction of miR‐708 to inhibit self‐renewal and chemoresistance of breast cancer stem cells through targeting CD47

2019 · Weige Tan, Hailin Tang, et al. · Journal of Cellular and Molecular Medicine · 65

PDF

The preoperative plasma fibrinogen level is an independent prognostic factor for overall survival of breast cancer patients who underwent surgical treatment

2015 · Jiahuai Wen, Yanning Yang, et al. · The Breast · 63

PDF

Development and validation of a prognostic nomogram based on the log odds of positive lymph nodes (LODDS) for breast cancer

2016 · Jiahuai Wen, Feng Ye, et al. · Oncotarget · 59

PDF

Inhibitor of glutamine metabolism V9302 promotes ROS-induced autophagic degradation of B7H3 to enhance antitumor immunity

2022 · Qian Li, Xiaofang Zhong, et al. · Journal of Biological Chemistry · 57

PDF

Multifunctional nanoparticles for co-delivery of paclitaxel and carboplatin against ovarian cancer by inactivating the JMJD3-HER2 axis

2017 · Jingxin Mo, Li Wang, et al. · Nanoscale · 56

PDF

EIF4A3-induced circZFAND6 promotes breast cancer proliferation and metastasis through the miR-647/FASN axis

2023 · Xiaojia Huang, Weige Tan, et al. · Life Sciences · 50

Pre-treatment serum alkaline phosphatase and lactate dehydrogenase as prognostic factors in triple negative breast cancer

2016 · Bo Chen, Danian Dai, et al. · Journal of Cancer · 48

PDF

Preoperative prediction nomogram based on primary tumor miRNAs signature and clinical‐related features for axillary lymph node metastasis in early‐stage invasive breast cancer

2017 · Xinhua Xie, Xinhua Xie, et al. · International Journal of Cancer · 46

Synergistic therapeutic effect of combined PDGFR and SGK1 inhibition in metastasis-initiating cells of breast cancer

2020 · Lu Yang, Ning Li, et al. · Cell Death and Differentiation · 45

PDF

Endothelial FoxM1 Mediates Bone Marrow Progenitor Cell-Induced Vascular Repair and Resolution of Inflammation following Inflammatory Lung Injury

2014 · Yidan D. Zhao, Yidan D. Zhao, et al. · Stem Cells · 44

PDF

Diallyl Disulfide Inhibits Breast Cancer Stem Cell Progression and Glucose Metabolism by Targeting CD44/PKM2/AMPK Signaling

2018 · Xinhua Xie, Xinhua Xie, et al. · Current Cancer Drug Targets · 40

SOX8 acts as a prognostic factor and mediator to regulate the progression of triple-negative breast cancer

2019 · Hailin Tang, Bo Chen, et al. · Carcinogenesis · 39

Prognostic Significance of Preoperative Circulating Monocyte Count in Patients With Breast Cancer

2015 · Jiahuai Wen, Feng Ye, et al. · Medicine · 38

Works count: 54

Citation count: 2,224

H-index: 28

I10-index: 35